We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,840 results
  1. Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma

    There is a critical need to identify new therapeutic vulnerabilities in pancreatic ductal adenocarcinoma (PDAC). Transcriptional co-regulators...

    Kranthi Kumar Chougoni, Haemin Park, ... Steven R. Grossman in Oncogenesis
    Article Open access 10 November 2023
  2. ERBB2 Targeting Reveals a Significant Suppression of Tumorigenesis in Murine Endometrial Cancer with Pten Mutation

    Endometrial cancer is the most common gynecologic malignancy. PTEN is a negative regulator of PI3K signaling and is deficient in > 50% of primary...

    Krystina Dunston, Mark I. Hunter, ... Jae-Wook Jeong in Reproductive Sciences
    Article 18 April 2024
  3. Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers

    Chimeric antigen receptor (CAR)-engineered immune effector cells constitute a promising approach for adoptive cancer immunotherapy. Nevertheless,...

    Jordi Pfeifer Serrahima, Congcong Zhang, ... Winfried S. Wels in Cancer Immunology, Immunotherapy
    Article Open access 23 January 2023
  4. Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy

    The appropriate and specific response of nerve cells to various external cues is essential for the establishment and maintenance of neural circuits,...

    Yan Guo, Pan **ang, ... **aozhong Peng in Signal Transduction and Targeted Therapy
    Article Open access 14 February 2024
  5. Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer

    Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective against non-small cell lung cancer (NSCLC) with EGFR -activating...

    Shiqi Ma, Lu Zhang, ... Bangrong Cao in Oncogene
    Article 09 March 2021
  6. Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

    Oesophageal adenocarcinoma (OAC) patients show poor survival rates and there are few targeted molecular therapies available. However, components of...

    Samuel Ogden, Kashmala Carys, ... Andrew D. Sharrocks in Oncogene
    Article Open access 24 September 2022
  7. Molecular insights of exercise therapy in disease prevention and treatment

    Despite substantial evidence emphasizing the pleiotropic benefits of exercise for the prevention and treatment of various diseases, the underlying...

    David Walzik, Tiffany Y. Wences Chirino, ... Niklas Joisten in Signal Transduction and Targeted Therapy
    Article Open access 29 May 2024
  8. Insulin and the insulin receptor collaborate to promote human gastric cancer

    Background

    Gastric adenocarcinoma is common and consequent mortality high. Presentation and mortality are increased in obese individuals, many of whom...

    Marina Saisana, S. Michael Griffin, Felicity E. B. May in Gastric Cancer
    Article Open access 23 September 2021
  9. BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436

    Purpose

    This study aims to find whether the proliferation and migration of triple negative breast cancer (TNBC) cell lines can be reduced by treatment...

    Maryana Teufelsbauer, Sandra Stickler, ... Gerhard Hamilton in Breast Cancer Research and Treatment
    Article Open access 19 June 2024
  10. ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia

    Sunil K. Joshi, Jamie M. Keck, ... Brian J. Druker in Leukemia
    Article Open access 04 May 2020
  11. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma

    Objective

    This study aimed to explore the efficacy and safety of combining epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)...

    Xue Han, Lan Liang, ... ** Zheng in BMC Complementary Medicine and Therapies
    Article Open access 21 November 2023
  12. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms’ tumor

    Purpose

    Wilms’ tumor is the most-frequent malignant-kidney tumor in children under 3–4 years of age and is caused by genetic alterations of oncogenes...

    Dinesh Kumar Sahu, Neetu Singh, ... Devendra Kumar Gupta in Pediatric Surgery International
    Article 15 September 2022
  13. ERRα: unraveling its role as a key player in cell migration

    Cell migration is essential throughout the life of multicellular organisms, and largely depends on the spatial and temporal regulation of...

    Jean-Marc Vanacker, Christelle Forcet in Oncogene
    Article 21 December 2023
  14. To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations

    Introduction

    Lung cancer is one of primary cancer type with high incidence and mortality, non-small cell lung cancer (NSCLC) is the most common type...

    Ruoxue Cai, Hongyu Zhu, ... Ying Fang in Journal of Cancer Research and Clinical Oncology
    Article Open access 01 June 2023
  15. Driver and targetable alterations in Chinese patients with small bowel carcinoma

    Purpose

    Small bowel carcinoma (SBA) is a rare gastrointestinal cancer with a poor prognosis. Recent genomic profiling studies revealed that the...

    Jun Li, **aomo Li, ... Wei Deng in Journal of Cancer Research and Clinical Oncology
    Article 21 January 2023
  16. Protein lipidation in health and disease: molecular basis, physiological function and pathological implication

    Posttranslational modifications increase the complexity and functional diversity of proteins in response to complex external stimuli and internal...

    Yuan Yuan, Peiyuan Li, ... **ngxing He in Signal Transduction and Targeted Therapy
    Article Open access 15 March 2024
  17. Investigation of HER2 I655V and PHB 3′UTR C > T polymorphisms in azoospermic infertile males

    Background

    Male infertility is a complex, multifactorial pathological condition with a highly heterogeneous phenotypic variation, from complete...

    Irem Yildiz, Nevin Karakus, Fikret Erdemir in Egyptian Journal of Medical Human Genetics
    Article Open access 10 July 2023
  18. AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors

    The PI3K pathway is commonly activated in breast cancer, with PI3K-AKT pathway inhibitors used clinically. However, mechanisms that limit or enhance...

    Shanade Dunn, Cath Eberlein, ... Kosuke Yusa in Oncogene
    Article Open access 14 October 2022
  19. Synchronous cancers of the stomach and esophagus in a patient with autoimmune gastritis and pernicious anemia: a case report and review of the literature

    Type-A gastritis/autoimmune gastritis (AIG) has gained renewed attention due to declining Helicobacter pylori infection rates and increasing...

    Toshiyuki Kubo, Yasushi Adachi, ... Akira Goto in International Cancer Conference Journal
    Article 04 June 2024
  20. HER2-Positive Metastatic Colorectal Cancer

    Targeted treatment strategies are available for human epidermal growth factor receptor 2 (HER2)–positive (amplified and/or overexpressed) metastatic...

    Hannah R. Robinson, Wells A. Messersmith, Robert W. Lentz in Current Treatment Options in Oncology
    Article 28 March 2024
Did you find what you were looking for? Share feedback.